Susquehanna International Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.9K | Buy |
80,311
+55,131
| +219% | +$61.7K | ﹤0.01% | 5915 |
|
|
2025
Q1 | $29K | Sell |
25,180
-7,187
| -22% | -$8.27K | ﹤0.01% | 6109 |
|
|
2024
Q4 | $198K | Buy |
32,367
+12,900
| +66% | +$78.8K | ﹤0.01% | 5316 |
|
|
2024
Q3 | $322K | Buy |
+19,467
| New | +$322K | ﹤0.01% | 4208 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6086 |
|
|
2024
Q1 | – | Sell |
-13,656
| Closed | -$113K | – | 6030 |
|
|
2023
Q4 | $113K | Buy |
+13,656
| New | +$113K | ﹤0.01% | 5295 |
|
|
2023
Q3 | – | Sell |
-41,941
| Closed | -$387K | – | 5923 |
|
|
2023
Q2 | $387K | Buy |
+41,941
| New | +$387K | ﹤0.01% | 3952 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6337 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6279 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6494 |
|
|
2022
Q2 | – | Sell |
-18,578
| Closed | -$497K | – | 6205 |
|
|
2022
Q1 | $497K | Sell |
18,578
-17,116
| -48% | -$458K | ﹤0.01% | 3726 |
|
|
2021
Q4 | $1.05M | Buy |
35,694
+2,709
| +8% | +$79.5K | ﹤0.01% | 2810 |
|
|
2021
Q3 | $2.17M | Buy |
32,985
+24,161
| +274% | +$1.59M | ﹤0.01% | 1880 |
|
|
2021
Q2 | $734K | Buy |
8,824
+4,958
| +128% | +$412K | ﹤0.01% | 3408 |
|
|
2021
Q1 | $296K | Buy |
3,866
+1,146
| +42% | +$87.7K | ﹤0.01% | 4379 |
|
|
2020
Q4 | $240K | Sell |
2,720
-4,559
| -63% | -$402K | ﹤0.01% | 4125 |
|
|
2020
Q3 | $537K | Buy |
+7,279
| New | +$537K | ﹤0.01% | 2931 |
|